Page last updated: 2024-08-26

lysophosphatidic acid and Depressive Disorder, Major

lysophosphatidic acid has been researched along with Depressive Disorder, Major in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Aoki, J; Boku, S; Hattori, K; Kajitani, N; Kano, K; Kunugi, H; Okada-Tsuchioka, M; Omori, W; Takebayashi, M1
Ahn, YM; Ha, K; Kim, EY; Kim, KP; Kim, SH; Lee, JW; Lee, MY; Mok, HJ1
Abe, H; Hattori, K; Itagaki, K; Kajitani, N; Kunugi, H; Okada-Tsuchioka, M; Shibasaki, C; Takebayashi, M; Yamawaki, S; Yoshida, S1

Other Studies

3 other study(ies) available for lysophosphatidic acid and Depressive Disorder, Major

ArticleYear
Reduced Cerebrospinal Fluid Levels of Lysophosphatidic Acid Docosahexaenoic Acid in Patients With Major Depressive Disorder and Schizophrenia.
    The international journal of neuropsychopharmacology, 2021, 12-08, Volume: 24, Issue:12

    Topics: Adult; Case-Control Studies; Chromatography, Liquid; Depressive Disorder, Major; Docosahexaenoic Acids; Female; Humans; Japan; Lysophospholipids; Male; Middle Aged; Phosphoric Diester Hydrolases; Schizophrenia

2021
Serum lipidomic analysis for the discovery of biomarkers for major depressive disorder in drug-free patients.
    Psychiatry research, 2018, Volume: 265

    Topics: Adult; Biomarkers; Depressive Disorder, Major; Female; Humans; Lipids; Lysophospholipids; Male; Middle Aged; Multivariate Analysis; Phosphatidylserines; Triglycerides

2018
Reduced Serum and Cerebrospinal Fluid Levels of Autotaxin in Major Depressive Disorder.
    The international journal of neuropsychopharmacology, 2019, 04-01, Volume: 22, Issue:4

    Topics: Adult; Aged; Depressive Disorder, Major; Electroconvulsive Therapy; Female; Humans; Lysophospholipids; Male; Middle Aged; Phosphoric Diester Hydrolases

2019